VERIFIEDMint Companies·13 May 2026neutral

Zydus to acquire US cancer drug company Assertio for $166.4 million in all-cash deal

AI Summary

·Zydus Lifesciences will acquire US-based cancer drug company Assertio for $166.4 million.
·The transaction will be an all-cash deal.
·This acquisition is part of Zydus' strategy to diversify and enhance its specialty offerings in regulated markets.